These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17322570)

  • 1. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the Society for Academic Emergency Medicine.
    Biros MH;
    Acad Emerg Med; 2007 Apr; 14(4):e27-9. PubMed ID: 17322570
    [No Abstract]   [Full Text] [Related]  

  • 2. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the American Stroke Association.
    Saver JL;
    Acad Emerg Med; 2007 Apr; 14(4):e57-8. PubMed ID: 17322569
    [No Abstract]   [Full Text] [Related]  

  • 3. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the American College of Emergency Physicians.
    Cairns CB;
    Acad Emerg Med; 2007 Apr; 14(4):e31-2. PubMed ID: 17331911
    [No Abstract]   [Full Text] [Related]  

  • 4. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Schmidt.
    Schmidt TA
    Acad Emerg Med; 2007 Apr; 14(4):e59-62. PubMed ID: 17331913
    [No Abstract]   [Full Text] [Related]  

  • 5. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Pediatric Emergency Care Applied Research Network.
    Chamberlain JM; Singh T; Baren JM; Maio RF;
    Acad Emerg Med; 2007 Apr; 14(4):e41-2. PubMed ID: 17322568
    [No Abstract]   [Full Text] [Related]  

  • 6. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Weisfeldt.
    Weisfeldt ML
    Acad Emerg Med; 2007 Apr; 14(4):e69. PubMed ID: 17331914
    [No Abstract]   [Full Text] [Related]  

  • 7. Food and Drug Administration public hearing of the conduct of emergency clinical research: testimony of Dr. Dutton.
    Dutton RP
    Acad Emerg Med; 2007 Apr; 14(4):e33-6. PubMed ID: 17400992
    [No Abstract]   [Full Text] [Related]  

  • 8. Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
    Weiskopf RB;
    Acad Emerg Med; 2007 Apr; 14(4):e71-3. PubMed ID: 17322571
    [No Abstract]   [Full Text] [Related]  

  • 9. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Nelson.
    Nelson RM
    Acad Emerg Med; 2007 Apr; 14(4):e43-4. PubMed ID: 17322567
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for implementation of community consultation and public disclosure under the Food and Drug Administration's "Exception from informed consent requirements for emergency research": a special report from the American Heart Association Emergency Cardiovascular Care Committee and Council on Cardiopulmonary, Perioperative and Critical Care: endorsed by the American College of Emergency Physicians and the Society for Academic Emergency Medicine.
    Halperin H; Paradis N; Mosesso V; Nichol G; Sayre M; Ornato JP; Gerardi M; Nadkarni VM; Berg R; Becker L; Siegler M; Collins M; Cairns CB; Biros MH; Vanden Hoek T; Peberdy MA; ;
    Circulation; 2007 Oct; 116(16):1855-63. PubMed ID: 17893277
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations for implementation of community consultation and public disclosure under the Food and Drug Administration "exception from informed consent requirements for emergency research": testimony of the American Heart Association.
    Halperin H;
    Acad Emerg Med; 2007 Apr; 14(4):e37-9. PubMed ID: 17400993
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to Food and Drug Administration draft guidance statement on research into the treatment of life-threatening emergency conditions using exception from informed consent: testimony of the Resuscitation Outcomes Consortium.
    Ornato JP
    Acad Emerg Med; 2007 Apr; 14(4):e45-9. PubMed ID: 17400994
    [No Abstract]   [Full Text] [Related]  

  • 13. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Pepe--defending the rights of all individuals to have access to potential life-saving therapies and resuscitation studies.
    Pepe PE
    Acad Emerg Med; 2007 Apr; 14(4):e51-6. PubMed ID: 17341677
    [No Abstract]   [Full Text] [Related]  

  • 14. Struggling with the rule: the exception from informed consent in resuscitation research.
    Biros M
    Acad Emerg Med; 2007 Apr; 14(4):344-5. PubMed ID: 17400997
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the final rule on the conduct of emergency clinical research.
    Gonzalez SK; Helling TS
    J Trauma; 2008 Jun; 64(6):1665-72. PubMed ID: 18545136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment and communication process for participation in the 2005 AEM Consensus Conference on the Ethical Conduct of Resuscitation Research: methodology, challenges, lessons learned.
    Baren JM; Nathanson PG
    Acad Emerg Med; 2005 Nov; 12(11):1027-30. PubMed ID: 16264069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Society for Academic Emergency Medicine position on informed consent for emergency medicine research.
    Marco CA;
    Acad Emerg Med; 2004 Oct; 11(10):1090-1. PubMed ID: 15466153
    [No Abstract]   [Full Text] [Related]  

  • 18. The Society for Academic Emergency Medicine position on ethical relationships with the biomedical industry.
    Schears RM; Watters A; Schmidt TA; Marco CA; Larkin GL; Marshall JP; Mason JD; McBeth BD; Mello MJ;
    Acad Emerg Med; 2007 Feb; 14(2):179-81. PubMed ID: 17185294
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to Food and Drug Administration draft guidance statement on research into the treatment of life-threatening emergency conditions using exception from informed consent: testimony of the neurological emergencies treatment trials.
    Silbergleit R;
    Acad Emerg Med; 2007 Apr; 14(4):e63-8. PubMed ID: 17331912
    [No Abstract]   [Full Text] [Related]  

  • 20. 31st Bethesda Conference. Emergency Cardiac Care. Task force 3: Special aspects of research conduct in the emergency setting: Waiver of informed consent.
    Passamani ER; Weisfeldt ML
    J Am Coll Cardiol; 2000 Mar; 35(4):862-80. PubMed ID: 10732882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.